2022-09-13T13:12:16-05:00 2021-12-31 111986323 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2021-01-01 510178702 RADIATION ONCOLOGY INSTITUTE RADI 7035021550 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 7035021550 2022-09-13 1 LAURA THEVENOT 999009999 AARON M FOX P01365820 2022274000 2022-09-13 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z LAURA I THEVENOT 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 18813577 0 X WWW.ROINSTITUTE.ORG X 1978 IL TO ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER. 11 11 0 50 0 0 619829 422102 0 0 533080 869371 0 0 1152909 1291473 186914 170667 0 0 337167 296632 0 0 278586 223523 230367 747604 697666 405305 593807 16106095 17490901 637 5490 16105458 17485411 X THE RADIATION ONCOLOGY INSTITUTE (ROI) WILL ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER BY SUPPORTING RESEARCH AND EDUCATION ABOUT THE LIFE-SAVING AND QUALITY-OF-LIFE BENEFITS OF RADIATION THERAPY. 0 0 91328 71816 TOXICITY MANAGEMENT PROJECT - DEALS WITH THE MANAGEMENT AND ON-GOING FOLLOW-UP OF ADVERSE EFFECTS RELATED TO RADIATION THERAPY. THE RADONC TOOLBOX APP AND WEBSITE WILL IMPROVE COMMUNICATION AND KNOWLEDGE AMONG NON-RADIATION THERAPY HEALTH CARE PROVIDERS IN ORDER TO IMPROVE PATIENT OUTCOMES AND QUALITY OF LIFE METRICS. A RESEARCH PROJECT USING ACTIVITY TRACKERS IS TESTING WHETHER A SIMPLE WALKING PROGRAM COULD LESSEN TREATMENT-RELATED TOXICITIES AND IMPROVE PATIENT QUALITY OF LIFE. 90987 86711 VALUE OF RADIATION THERAPY: ROI SUPPORTS RESEARCH THAT DEMONSTRATES THE VALUE OF TECHNOLOGIES AND INTERVENTIONS IN RADIATION ONCOLOGY BY ASSESSING VARIOUS FACTORS AFFECTING PATIENTS AND PROVIDERS INCLUDING HEALTH BENEFITS, SIDE-EFFECTS, QUALITY OF LIFE, COST AND PRODUCTIVITY LOSS. RADIATION THERAPY OPTIONS ARE OFTEN UNDERUTILIZED, AND THIS TYPE OF RESEARCH GENERATES EVIDENCE AND TOOLS TO ENHANCE TREATMENT SELECTION FOR IMPROVED OUTCOMES. 13549 4981 PUBLICATION AWARD: THE ROI PUBLICATION AWARD RECOGNIZES THE BEST SCIENTIFIC WORK BY AN EARLY CAREER INVESTIGATOR IN ONE OF THE PRIORITY AREAS FOR RADIATION ONCOLOGY THAT FORM THE ROI'S RESEARCH AGENDA: COMMUNICATION, SAFETY AND QUALITY, TOXICITY MANAGEMENT, COMPARATIVE EFFECTIVENESS, AND VALUE. 49550 OTHER PROGRAM SERVICES: RESEARCH COMMITTEE, DECISION MAKING PROJECT, AND DEL REGATO. 49550 245414 1 1 0 0 0 0 0 0 0 1 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 10 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 IL VA X PATRICIA B LAWLOR 7035021550 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 DEBORAH A KUBAN PRESIDENT 1.00 X X 0 0 0 COLLEEN A F LAWTON VICE PRESIDENT 1.00 X X 0 0 0 JAMES P HOEY TREASURER 1.00 X X 0 0 0 DANIEL MOORE TRUSTEE 1.00 X 0 0 0 KOLLEEN T KENNEDY TRUSTEE 1.00 X 0 0 0 CHRISTOPHER M ROSE TRUSTEE 1.00 X 0 0 0 TIM WILLIAMS TRUSTEE 1.00 X 0 0 0 J FRANK WILSON DEVELOPMENT COMMITTEE CHAIR AND TRUSTEE 1.00 X 0 0 0 GITA SUNEJA RESEARCH COMMITTEE CHAIR AND TRUSTEE 1.00 X 0 0 0 THEODORE DEWEESE ASTRO REPRESENTATION - TERM ENDED 10/21 1.00 X 0 0 0 CATHERINE PARK ASTRO REPRESENTATION - TERM ENDED 10/21 1.00 X 0 0 0 JASON A EFSTATHIOU TRUSTEE 1.00 X 0 0 0 THOMAS J EICHLER ASTRO REPRESENTATION - TERM STARTED 10/21 1.00 X 0 0 0 BRIAN MARPLES ASTRO REPRESENTATION - TERM STARTED 10/21 1.00 X 0 0 0 LAURA I THEVENOT EXEC. DIR., SECR. AND ASST. TREAS. 4.00 36.00 X 0 724118 86169 0 724118 86169 0 0 1 0 0 12685 409417 422102 717127 717127 17674348 17522104 152244 152244 152244 1291473 0 0 869371 170667 170667 296632 52133 86800 157699 1666 1176 490 12805 12805 34587 34587 25090 4500 20590 24756 253 10122 14381 83853 17262 24232 42359 3780 3780 31365 31365 3112 3112 DUES AND PUBLICATIONS 9254 599 832 7823 STAFF TRAINING 99 99 697666 245414 173666 278586 208907 176370 277012 275577 217194 64869 5730 5081 5531 13622591 13840134 1929070 2906340 0 62590 16106095 17490901 637 5490 637 5490 X 2820965 3093784 13284493 14391627 16105458 17485411 16106095 17490901 593807 786146 0 X 0 1 X 1 0 X X 1 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 420943164 10 0 10000 0 1 10000 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 3B: ROI IS THE SUPPORTING ORGANIZATION FOR THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A 501(C)(6) ORGANIZATION. ROI PERFORMED THE 509(A)(2) TEST FOR ASTRO AND FOUND THAT ASTRO'S SUPPORT PERCENTAGE EXCEEDS THE 33% MINIMUM OF PUBLIC SUPPORT THAT WOULD BE A REQUIREMENT IF ASTRO WERE DESCRIBED AS SUCH AN ENTITY. ACCORDINGLY, ROI IS ELIGIBLE TO SUPPORT ASTRO. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 12559467 12685 1343949 182272 13733829 11274198 70506 1437601 222836 12559469 9555386 88600 1825121 194909 11274198 10457820 136653 -771235 267852 9555386 9169439 198633 1281972 192224 10457820 0.00000 0.81000 0.19000 0 0 0 SKYBRIDGE 516627 C PARTNERS GROUP FUND 588885 C IRONWOOD 945 C BLACKSTONE BREIT 799883 C REALTY CORE 1000000 C 2906340 X 2073587 786146 30555 816701 1256886 34587 34587 1291473 693634 30555 30555 663079 34587 34587 697666 PART V, LINE 4: CURRENTLY, THE ENDOWMENT FUND IS A PERMANENTLY RESTRICTED FUND WHICH IS NOT AVAILABLE FOR USE. PART X, LINE 2: ROI PERFORMED AN EVALUATION OF UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED DECEMBER 31, 2021, AND DETERMINED THAT THERE ARE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. 1 BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 25000 0 SERIAL MRIRADIOMIC BIOMARKER TO PERDICT CEREBRAL RADIATION NECROSIS JOHN HOPKINS UNIVERSITY 3910 KESWICK RD BALTIMORE MD 21211 520595110 501(C)(3) 24874 0 AN INCLUSIVE GRADING SYSTEM FOR ASSESSING ACUTE RADIATION ONCOLOGY FUNDING OPPORTUNITY UNIVERSITY TX SOUTHWESTERN MEDICAL CENTER DALLAS 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501(C)(3) 37472 0 CIRCULATING EXOSOME-BASED BIOMARKER FOR TREATMENT MONITORING IN ANAL CANCER MASSACHUSETTS GENERAL HOSPITAL-RESEARCH FINANCE 55 FRUIT ST BOSTON MA 02114 042697983 501(C)(3) 62461 0 LIQUID BIOPSY-GUIDED TRIMODALITY THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER UNIVERSITY OF TX MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 746001118 501(C)(3) 24250 0 MICROBIOME PROFILE AS A BIOMARKER OF RESPONSE IN RESECTED PANCREATIC CANCER REGENTS OF THE UNIVERSITY OF MINNESOTA 2221 UNIVERSITY AVE SE MINNEAPOLIS MN 55414 416007513 501(C)(3) 15642 0 EVALUATION OF DISPARITIES IN ONCOLOGY CARE AMONG THE LGBTQ COMMUNITY RUTGERS THE STATE UNIVERSITY OF NEW JERSEY 33 KNIGHTSBRIDGE RD PISCATAWAY NJ 088543925 226001086 501(C)(3) 15000 0 RECRUITING MORE UNDERREPRESENTED MINORITY STUDENTS INTO RADIATION ONCOLOGY ASTRO 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 501(C)(6) 10000 0 2021 ROI SUPPORT TO ARRO WEBINAR 7 0 PART I, LINE 2: SIGNED AWARD LETTERS OUTLINE THE TERMS AND CONDITIONS OF ACCEPTANCE AND USE OF THE RESEARCH AWARD. AS PER THE SIGNED AGREEMENT, AN INTERIM PROGRESS REPORT AND A FINAL REPORT ARE COLLECTED WHICH SUMMARIZE PROGRESS MADE AND EXPENDITURES. 0 0 0 0 0 0 0 0 0 LAURA I THEVENOT EXEC. DIR., SECR. AND ASST. TREAS. 0 554182 0 99483 0 70453 0 40000 0 46169 0 810287 0 0 PART I, LINE 3 ROI DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). AN INDEPENDENT CONSULTANT PERFORMED A MARKET SURVEY TO DEVELOP SALARY STRUCTURE AND RANGES. ASTRO'S PRACTICE IS TO COMPLETE A MARKET SURVEY EVERY THREE YEARS; THIS WAS LAST COMPLETED FOR THE EX-OFFICIO, EXECUTIVE DIRECTOR IN 2019. THE EX-OFFICIO, EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY A SUBCOMMITTEE OF THE BOARD USING COMPARABLE SALARIES OF SIMILAR EXECUTIVE DIRECTOR POSITIONS OF NONPROFIT MEDICAL ORGANIZATIONS. THIS REVIEW WAS DISCUSSED WITH THE BOARD OF DIRECTORS AND THE FINAL DETERMINATION WAS MADE BY THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION A, LINE 3 ALL MANAGEMENT FUNCTIONS OF ROI ARE CONTROLLED BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990 IS PREPARED BY OUR EXTERNAL TAX ACCOUNTANTS. THE DRAFT IS PROVIDED TO OUR FINANCE STAFF FOR REVIEW BEFORE BEING SUBMITTED TO THE VP FINANCE & ADMINISTRATION, CEO, AND TREASURER OF ASTRO FOR THEIR REVIEW AND APPROVAL. THE REVISED DRAFT IS THEN PROVIDED TO THE FULL BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ROI'S OFFICERS, DIRECTORS, KEY EMPLOYEES, AND VOLUNTEERS ARE REQUIRED TO FILL OUT DISCLOSURE FORMS ON AN ANNUAL BASIS AND TO UPDATE THEIR DISCLOSURE FORMS UPON ANY MATERIAL CHANGE IN THE INTERIM. THESE DISCLOSURE FORMS ARE REVIEWED IN ORDER TO IDENTIFY AND ADDRESS ANY POTENTIAL CONFLICTS OF THESE INDIVIDUALS. FORM 990, PART VI, SECTION C, LINE 19 THE SUMMARY FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICIES ARE AVAILABLE ON OUR WEBSITE. AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 MEMBERSHIP SOCIETY IL 501(C)(6) 501(C)(6) N/A 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 AMERICAN SOCIETY FOR RADIATION ONCOLOGY C 12685 ACTUAL AMERICAN SOCIETY FOR RADIATION ONCOLOGY N 83853 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY O 296632 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY B 10000 ACTUAL AMERICAN SOCIETY FOR RADIATION ONCOLOGY P 62590 FMV